RenovoRx, Inc. ("RenovoRx" or "the Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing ...

A year of strategic execution concluded with a strong Q4 Fourth quarter 2025 (October - December) Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to 3.9% ...

Introduction Mobile health (mHealth) technologies have become increasingly popular for monitoring mental health symptoms and lifestyle behaviours, and are largely reported to be feasible and ...

Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...

Introduction Duplicate medical records occur when a single patient is assigned multiple medical record numbers within an ...

Today, Midi Health is worth over $1 billion. The fastest-growing women’s telehealth platform announced its valuation on ...

Los Angeles, California - January 20, 2026 - PRESSADVANTAGE - Rocket CRM, a software platform, has released an ...